2017-03-17,AcelRx Pharmaceuticals To Participate At Three Upcoming Investor Events In March And April
2017-03-01,AcelRx Pharmaceuticals To Participate At Two Upcoming Investor Events In March
2017-02-27,AcelRx Pharmaceuticals' New Drug Application For DSUVIA Accepted For Filing With PDUFA Date Of October 12, 2017
2017-02-23,AcelRx Pharmaceuticals To Hold Annual 2016 Financial Results Conference Call And Webcast On Thursday, March 2nd, 2017
2017-02-16,AcelRx Pharmaceuticals Appoints Vincent J. Angotti Chief Executive Officer
2017-02-07,AcelRx Pharmaceuticals To Participate At Four Upcoming Investor Events In February
2017-01-08,AcelRx Pharmaceuticals Provides Guidance On 2017 Milestones For ARX-04, Now Known As DSUVIA™ In The United States, For The Treatment Of Moderate-to-Severe Acute Pain
2017-01-08,AcelRx Pharmaceuticals Announces DSUVIA™ As Brand Name For ARX-04 In The United States
2016-12-13,AcelRx Pharmaceuticals Submits New Drug Application For ARX-04 For The Treatment Of Moderate-To-Severe Acute Pain
2016-12-06,AcelRx Pharmaceuticals Reports On ARX-04 Market And Landscape Presented At Analyst & Investor Event
2016-11-28,AcelRx Pharmaceuticals Updates Agenda For Analyst & Investor Event Focusing On Innovative Therapies For Treatment Of Acute Pain
2016-11-09,AcelRx Pharmaceuticals To Host Analyst & Investor Event On December 1, 2016
2016-11-08,AcelRx Pharmaceuticals To Participate At Three Upcoming Investor Events In November
2016-10-25,AcelRx Pharmaceuticals To Hold Third Quarter Financial Results Conference Call And Webcast On Tuesday, November 1st, 2016
2016-10-13,ACRX: Insiders vs. Shorts
2016-09-27,AcelRx Initiates Phase 3 Study Of Zalviso® In Patients With Moderate-to-Severe Acute Post-Operative Pain
2016-09-22,AcelRx Pharmaceuticals To Present At The Ladenburg Thalmann 2016 Healthcare Conference
2016-09-15,Here's Why AcelRx Pharmaceuticals (ACRX) Stock Gained Today
2016-09-15,AcelRx Reports Positive Results For ARX-04 (sufentanil Sublingual Tablet, 30 Mcg), Including In Elderly Patients And Patients With Organ Impairment, In Third Phase 3 Registration Trial, SAP303
2016-09-14,AcelRx Pharmaceuticals To Announce Topline Results In Phase 3 Study Of ARX-04 In Patients With Post-Operative Moderate-to-Severe Acute Pain
2016-08-31,AcelRx Pharmaceuticals to Participate at Two Upcoming Investor Events in September
2016-08-15,AcelRx Pharmaceuticals' ARX-04 Phase 3 Trial Met Its Primary Endpoint, Reduced Pain Intensity In ER Patients With Moderate-to-Severe Acute Pain
2016-07-26,AcelRx Pharmaceuticals To Hold Second Quarter Financial Results Conference Call And Webcast On Thursday, July 28th, 2016
2016-07-06,AcelRx Pharmaceuticals To Present At Cantor Fitzgerald 2nd Annual Healthcare Conference
2016-06-28,AcelRx Pharmaceuticals Completes Patient Enrollment In Remaining Phase 3 Studies Of ARX-04 As A Potential Treatment Of Moderate-to-Severe Acute Pain
2016-06-27,AcelRx Pharmaceuticals Joins Russell 3000 And Russell 2000 Indexes
2016-06-02,AcelRx Pharmaceuticals To Participate In Three Upcoming Healthcare Investor Events In June
2016-05-04,AcelRx Pharmaceuticals To Present At Two Upcoming Investor Events In May
2016-04-28,AcelRx Pharmaceuticals To Hold First Quarter Financial Results Conference Call And Webcast On Monday, May 2nd, 2016
2016-03-29,AcelRx Pharmaceuticals Names Howard B. Rosen As Chief Executive Officer And Provides Update On Clinical Development Activities And Corporate Priorities For 2016
2016-03-25,AcelRx Publishes A Review Of Hospital-Based Opioid Patient-Controlled Analgesia, Risks And Pharmacoeconomics
2016-03-14,AcelRx Pharmaceuticals Advances ARX-04 into Extension Phase of Open-Label Phase 3 Emergency Room Study
2016-03-07,AcelRx Pharmaceuticals Initiates Phase 3 Study Of ARX-04 In Patients With Post-Operative Moderate-to-Severe Acute Pain
2016-03-03,AcelRx Pharmaceuticals To Hold Annual 2015 Financial Results Conference Call And Webcast On Monday, March 7th, 2016.
2016-03-01,AcelRx Pharmaceuticals To Present At Two Upcoming Investor Events In March
2016-02-25,AcelRx Pharmaceuticals' Moderate-to-Severe Acute Pain Candidate ARX-04 Shows Improved Pain Scores In ER Patients In Interim Phase 3 Analysis
2016-02-03,AcelRx Pharmaceuticals To Present At Two Upcoming Investor Events In February
2016-01-27,First Week of ACRX September 16th Options Trading
2016-01-21,AcelRx Pharmaceuticals Announces Presentation Of Phase 3 Sufentanil Sublingual 30 Mcg Tablet (ARX-04) Data At The European Congress Of Ambulatory Surgery
2016-01-10,AcelRx Pharmaceuticals Announces Anticipated 2016 Milestones
2016-01-08,AcelRx Completes Protocol Review With FDA And Plans To Initiate Phase 3 Open-Label Study (IAP312) For Zalviso™ In 1Q 2016
2015-12-23,AcelRx Pharmaceuticals Receives Notice Of Eligibility For Centralized Review Of ARX-04 From European Medicines Agency
2015-12-14,AcelRx Pharmaceuticals Conducts Pre-NDA Meeting with U.S. Food and Drug Administration for ARX-04
2015-12-02,AcelRx Pharmaceuticals (ACRX) Highlighted As Weak On High Volume
2015-11-23,AcelRx Pharmaceuticals To Present At Piper Jaffray 27th Annual Healthcare Conference
2015-11-13,AcelRx Pharmaceuticals (ACRX) Strong On High Relative Volume Today
2015-11-10,AcelRx Pharmaceuticals To Present At Jefferies 2015 Global Healthcare Conference
2015-11-05,AcelRx Pharmaceuticals To Present At Credit Suisse 24th Annual Healthcare Conference
2015-11-04,AcelRx Pharmaceuticals Presents Data From Phase 3 Clinical Trials Evaluating The Safety And Efficacy Of Zalviso In Obese Surgical Patients
2015-10-26,AcelRx Pharmaceuticals To Hold Business Update And Third Quarter Financial Results Conference Call And Webcast On Thursday, Oct 29th, 2015
2015-10-23,AcelRx Pharmaceuticals Announces Presentation Of Phase 3 Data From ARX-04 Sufentanil Sublingual 30 Mcg Program At The American Society Of Anesthesiology Meeting
2015-10-08,AcelRx Pharmaceuticals Provides Regulatory Update On Zalviso
2015-10-06,AcelRx Pharmaceuticals Announces Initiation Of Clinical Study With ARX-04 In Emergency Room Patients With Moderate-to-Severe Acute Pain
2015-10-02,Amicus, Other Biotech CEOs Should Listen More, Talk Less About FDA Matters
2015-10-01,AcelRx Pharmaceuticals Appoints Gina Ford As Vice President Commercial Strategy
2015-09-24,AcelRx Pharmaceuticals To Host Analyst & Investor Event On October 2, 2015
2015-09-22,AcelRx Pharmaceuticals Reports That The European Commission Has Granted Marketing Authorization For Zalviso™ For Treatment Of Acute Moderate-to-Severe Post-Operative Pain In Adult Patients
2015-09-21,PDL BioPharma Acquires A Portion Of AcelRx Pharmaceuticals' Expected Royalties And Commercial Milestones From Zalviso™ For $65 Million
2015-09-21,AcelRx Pharmaceuticals Receives $65 Million From The Partial Sale Of Zalviso™ European Royalties And Commercial Milestones To PDL BioPharma
2015-09-09,AcelRx Pharmaceuticals' ARX-04 Meets All Endpoints In Pivotal Phase 3 Study For Moderate-to-Severe Acute Pain
2015-08-26,AcelRx Pharmaceuticals To Participate At Three Investor Conferences In September
2015-07-29,AcelRx Pharmaceuticals To Hold Business Update And Second Quarter Financial Results Conference Call And Webcast On Monday, Aug. 3rd, 2015.
2015-07-24,5 Stocks Poised for Breakouts
2015-07-24,AcelRx Announces Positive CHMP Opinion For Zalviso In The Management Of Acute Moderate-to-Severe Post-Operative Pain In Adult Patients
2015-07-14,3 Stocks Under $10 to Trade for Breakouts
2015-07-02,Zalviso™ Phase 3 Orthopedic Results Published In Anesthesiology Demonstrate Significant Reductions In Post-Operative Pain
2015-07-01,10 Worst Biotech Stocks in the NASDAQ
2015-05-22,AcelRx Pharmaceuticals To Present At Two Upcoming Investor Conferences In June
2015-05-14,AcelRx Awarded Contract From Department Of Defense To Advance ARX-04
2015-05-08,Insider Trading Alert - LAD, RSE And ACRX Traded By Insiders
2015-05-01,AcelRx Pharmaceuticals To Participate At Upcoming Investor Conferences In May
2015-04-30,AcelRx Pharmaceuticals To Hold First Quarter Financial Results Conference Call And Webcast On Monday, May 4th, 2015
2015-04-24,Insider Trading Alert - STFC, ACRX And CSC Traded By Insiders
2015-03-23,AcelRx Pharmaceuticals: What Went Wrong and What's on the Horizon for the Struggling Biotech?
2015-03-20,AcelRx Appoints Howard B. Rosen As Interim CEO
2015-03-16,AcelRx Pharmaceuticals Announces Initiation Of Pivotal Phase 3 Trial For ARX-04
2015-03-13,INVESTOR ALERT: Faruqi & Faruqi, LLP Encourages Investors Who Suffered Losses In Excess Of $100,000 Investing In AcelRx Pharmaceuticals, Inc. (ACRX) To Contact The Firm
2015-03-10,AcelRx Pharmaceuticals (ACRX) Stock Extends Losses Today as Jefferies Downgrades
2015-03-09,EQUITY ALERT: The Rosen Law Firm Announces Investigation Of Securities Claims Against AcelRx Pharmaceuticals, Inc. - ACRX
2015-03-09,AcelRx Pharmaceuticals (ACRX) Stock Tanks Today on FDA Demand For Further Zalviso Trials
2015-03-09,AcelRx Pharmaceuticals Is Now Oversold (ACRX)
2015-03-09,SHAREHOLDER ALERT: Pomerantz Law Firm Investigates Claims On Behalf Of Investors Of AcelRx Pharmaceuticals, Inc. - ACRX
2015-03-09,AcelRx Provides Regulatory Update On Zalviso
2015-03-04,AcelRx Pharmaceuticals To Hold Annual 2014 Financial Results Conference Call And Webcast On Monday, March 9th, 2015
2015-02-20,AcelRx Pharmaceuticals To Participate At Two Upcoming Investor Events
2015-02-04,AcelRx Pharmaceuticals To Present At BIO CEO & Investor Conference
2015-01-15,Will the Second Time be a Charm for Biotech AcelRx After Their FDA Rejection?
2015-01-09,5 Stocks Under $10 Setting Up to Trade Higher: Callon Petroleum and More
2014-12-30,AcelRx Pharmaceuticals (ACRX) Downgraded From Hold to Sell
2014-12-29,Ratings Changes Today
2014-12-02,AcelRx Pharmaceuticals Receives CE Mark Approval For Zalviso
2014-11-20,AcelRx Pharmaceuticals To Participate In Four Upcoming Investor Events
2014-11-19,SHAREHOLDER ALERT: Brower Piven Encourages Investors Who Have Losses In Excess Of $100,000 From Investment In AcelRx Pharmaceuticals, Inc. To Contact Brower Piven Before The December 1, 2014 Lead Plaintiff Deadline In Class Action Lawsuit
2014-11-17,UPCOMING DEADLINE: Levi & Korsinsky, LLP Reminds Investors Of Class Action Against AcelRx Pharmaceuticals, Inc. And Its Board Of Directors And A Lead Plaintiff Deadline Of December 1, 2014
2014-11-12,AcelRx Pharmaceuticals (ACRX) Upgraded From Sell to Hold
2014-11-11,AcelRx Pharmaceuticals (ACRX) Stock Rises After Third-Quarter Earnings Report
2014-11-11,Ratings Changes Today
2014-11-10,AcelRx Pharmaceuticals Receives International Standards Organization (ISO) 13485:2003 Certification Of Its Quality Management System
2014-11-07,AcelRx Pharmaceuticals To Participate In Two Upcoming Investor Events
2014-11-06,INVESTOR ALERT: Glancy Binkow & Goldberg LLP Reminds Investors Of The Lead Plaintiff Deadline In The Class Action Lawsuit Against AcelRx Pharmaceuticals, Inc.
2014-11-06,AcelRx Pharmaceuticals To Hold Third Quarter Financial Results Conference Call And Webcast On Monday, November 10, 2014
2014-11-05,Acelrx Pharmaceuticals Announces Management Change
2014-10-27,AcelRx Pharmaceuticals Announces Sublingual Sufentanil Data Presentations At The American College Of Surgeons Meeting
2014-10-22,AcelRx Announces Publication Of Zalviso Phase 3 Abdominal Trial Results
2014-10-16,AcelRx Pharmaceuticals Provides Update On Its Patent Portfolio For Zalviso™ And Its Proprietary Platform Technologies
2014-10-15,SHAREHOLDER ALERT: Brower Piven Encourages Investors Who Have Losses In Excess Of $100,000 From Investment In AcelRx Pharmaceuticals, Inc. To Contact Brower Piven Before The December 1, 2014 Lead Plaintiff Deadline In Class Action Lawsuit
2014-10-07,Harwood Feffer LLP Announces Investigation Of AcelRx Pharmaceuticals, Inc.
2014-10-07,Lifshitz & Miller Law Firm Announces Investigation Of AcelRx Pharmaceuticals, Inc., Ambit Biosciences, Athlon Energy Inc., LipoScience, Inc., Simplicity Bancorp, Inc., And TIBCO Software Inc.
2014-10-07,AcelRx Pharmaceuticals Shareholder Alert: Former SEC Attorney Willie Briscoe And Powers Taylor Investigate Possible Breaches Of Fiduciary Duty By Officers And Directors
2014-10-03,INVESTOR ALERT: Faruqi & Faruqi, LLP Encourages Investors Who Suffered Losses In Excess Of $50,000 Investing In AcelRx Pharmaceuticals, Inc. (ACRX) To Contact The Firm
2014-10-02,INVESTOR ALERT: Class Action Lawsuit Against AcelRx Pharmaceuticals, Inc. Filed By Glancy Binkow & Goldberg LLP
2014-09-29,Strong On High Volume: AcelRx Pharmaceuticals (ACRX)
2014-09-26,Why AcelRx Pharmaceuticals (ACRX) Stock Hit a One-Year Low Today
2014-09-26,AcelRx Pharmaceuticals Provides Regulatory Update On Zalviso™
2014-09-10,AcelRx Announces Publication Of Manuscript Analyzing Cost Of Intravenous Patient-Controlled Analgesia With Opioids
2014-09-04,AcelRx Announces Publication Of Sufentanil Sublingual Tablet System Vs. Intravenous Patient-Controlled Analgesia With Morphine For Postoperative Pain Study Results
2014-08-27,AcelRx Pharmaceuticals To Participate In Two Upcoming Investor Events
2014-08-26,The Best Hedge Fund You've Never Heard Of and Its Top 5 Stock Picks
2014-08-08,AcelRx Pharmaceuticals To Participate In Three Upcoming Investor Events
2014-08-07,AcelRx Pharmaceuticals To Hold Second Quarter Financial Results Conference Call And Webcast On Monday, August 11th, 2014.
2014-08-01,Perilous Reversal Stock: AcelRx Pharmaceuticals (ACRX)
2014-08-01,4 Biotech Stocks Under $10 to Trade for Breakouts
2014-07-29,Today's Dead Cat Bounce Stock: AcelRx Pharmaceuticals (ACRX)
2014-07-28,Why AcelRx Pharmaceuticals (ACRX) Stock Is Plummeting Today
2014-07-28,FDA Rejects AcelRx Painkiller Dispensing Device (Update)
2014-07-28,AcelRx Pharmaceuticals (ACRX) Moving On Heavy Volume In The Pre-Market Hours
2014-07-25,AcelRx Pharmaceuticals Receives Complete Response Letter From FDA For New Drug Application For Zalviso™
2014-07-24,AcelRx Pharmaceuticals Confirms July 27, 2014 PDUFA Date For Zalviso
2014-07-24,4 Biotech Stocks Breaking Out on Big Volume
2014-07-18,Biotech Stock Mailbag: AcelRx, Yellen Aftermath, Nymox
2014-07-14,Biotech Stock Mailbag: MannKind, Bluebird, Northwest Bio, More '14 Tradable Biotech Events
2014-07-07,AcelRx And Grunenthal Announce Submission Of European Marketing Authorization Application For ZALVISO™
2014-07-03,5 Stocks Spiking on Unusual Volume
2014-06-25,First Week of August 16th Options Trading For AcelRx Pharmaceuticals (ACRX)
2014-06-19,AcelRx Pharmaceuticals To Present At The JMP Securities Healthcare Conference
2014-06-06,Oversold Conditions For AcelRx Pharmaceuticals (ACRX)
2014-06-03,Results Of Cost Analysis Study Presented At ISPOR Meeting Identify Intravenous Patient-Controlled Analgesia (IV PCA) Costs Of $200 To $240 For Two Days Of Post-Surgical Pain Management
2014-05-29,AcelRx Pharmaceuticals To Present At The Jefferies Global Healthcare Conference
2014-05-19,AcelRx Pharmaceuticals To Present At The UBS Global Healthcare Conference
2014-05-14,AcelRx Pharmaceuticals is Now Oversold (ACRX)
2014-05-02,AcelRx Pharmaceuticals To Hold First Quarter Financial Results Conference Call And Webcast On Thursday, May 8, 2014
2014-05-01,AcelRx Pharmaceuticals Announces Zalviso&#8482; And ARX-04 Data Presentations At The American Pain Society 33rd Annual Scientific Meeting
2014-04-25,First Week of ACRX December 20th Options Trading
2014-04-04,AcelRx Pharmaceuticals To Present At The 13th Annual Needham Healthcare Conference
2014-03-27,Interesting ACRX Put And Call Options For May 17th
2014-03-25,AcelRx Pharmaceuticals Appoints Timothy E. Morris As Chief Financial Officer
2014-03-07,AcelRx Pharmaceuticals To Participate At The 26th Annual Roth Conference
2014-02-24,AcelRx Pharmaceuticals To Hold Fourth Quarter And Annual 2013 Financial Results Conference Call And Webcast On Monday, March 3, 2014
2014-02-05,AcelRx Pharmaceuticals To Participate In Three Upcoming Investor Events
2013-12-30,First Week of ACRX February 2014 Options Trading
2013-12-19,AcelRx Secures $40 Million Credit Facility With Hercules Technology Growth Capital
2013-12-16,AcelRx And Grunenthal Announce Collaboration For EU Commercialization Of ZALVISO&#8482;
2013-12-13,AcelRx Pharmaceuticals Presents ARX-04 Dose-Finding Phase 2 Study Data At Anesthesia Medical Conference
2013-12-11,AcelRx Pharmaceuticals Adds New Board Member
2013-12-02,Zalviso&#8482; New Drug Application Accepted For Filing By FDA
2013-11-26,AcelRx Pharmaceuticals To Present At The 25th Annual Piper Jaffray Healthcare Conference
2013-11-19,First Week Of ACRX January 2014 Options Trading
2013-11-13,5 Stocks With Big Insider Buying
2013-11-13,Top Insider Trades: AGCO VVUS INWK ACRX
2013-11-06,Oversold Conditions For AcelRx Pharmaceuticals (ACRX)
2013-11-05,Top Insider Trades: ACW ZINC ACRX FCX
2013-10-23,First Week Of ACRX June 2014 Options Trading
2013-10-22,AcelRx Pharmaceuticals To Hold Third Quarter 2013 Financial Results Conference Call And Webcast On November 5, 2013
2013-10-15,AcelRx Pharmaceuticals Announces Data Presentations For Zalviso™ At US And International Medical Meetings
2013-10-14,AcelRx Pharmaceuticals Becomes Oversold (ACRX)
2013-10-08,AcelRx Pharmaceuticals Provides Update On Its Patent Portfolio For Zalviso™ And Its Proprietary Platform Technologies
2013-09-30,AcelRx Pharmaceuticals Submits New Drug Application To The FDA For Zalviso™
2013-09-27,5 Stocks Poised for Breakouts
2013-09-04,David H. Chung Joins AcelRx Pharmaceuticals As Chief Commercial Officer
2013-08-30,AcelRx Pharmaceuticals To Present At The Stifel Healthcare Conference 2013
2013-08-05,5 Stocks Ready to Break Out
2013-08-05,AcelRx Pharmaceuticals To Present At Canaccord Genuity 33rd Annual Growth Conference
2013-08-02,AcelRx Pharmaceuticals To Hold Second Quarter 2013 Financial Results Conference Call And Webcast On August 12, 2013
2013-07-31,5 Stocks With Big Insider Buying
2013-07-25,Top Insider Trades: ACRX EBAY RLGY BERY
2013-07-23,AcelRx Pharmaceuticals Announces Closing Of Public Offering And Exercise Of Option To Purchase Additional Shares
2013-07-18,AcelRx Pharmaceuticals Announces Pricing Of Public Offering Of Common Stock
2013-07-17,AcelRx Pharmaceuticals Announces Proposed Public Offering Of Common Stock
2013-07-08,5 Stocks Spiking on Unusual Volume
2013-07-02,AcelRx Pharmaceuticals Joins Russell Global And Russell 3000 Indexes
2017-03-17,AcelRx Pharmaceuticals To Participate At Three Upcoming Investor Events In March And April
2017-03-01,AcelRx Pharmaceuticals To Participate At Two Upcoming Investor Events In March
2017-02-27,AcelRx Pharmaceuticals' New Drug Application For DSUVIA Accepted For Filing With PDUFA Date Of October 12, 2017
2017-02-23,AcelRx Pharmaceuticals To Hold Annual 2016 Financial Results Conference Call And Webcast On Thursday, March 2nd, 2017
2017-02-16,AcelRx Pharmaceuticals Appoints Vincent J. Angotti Chief Executive Officer
2017-02-07,AcelRx Pharmaceuticals To Participate At Four Upcoming Investor Events In February
2017-01-08,AcelRx Pharmaceuticals Provides Guidance On 2017 Milestones For ARX-04, Now Known As DSUVIA™ In The United States, For The Treatment Of Moderate-to-Severe Acute Pain
2017-01-08,AcelRx Pharmaceuticals Announces DSUVIA™ As Brand Name For ARX-04 In The United States
2016-12-13,AcelRx Pharmaceuticals Submits New Drug Application For ARX-04 For The Treatment Of Moderate-To-Severe Acute Pain
2016-12-06,AcelRx Pharmaceuticals Reports On ARX-04 Market And Landscape Presented At Analyst & Investor Event
2016-11-28,AcelRx Pharmaceuticals Updates Agenda For Analyst & Investor Event Focusing On Innovative Therapies For Treatment Of Acute Pain
2016-11-09,AcelRx Pharmaceuticals To Host Analyst & Investor Event On December 1, 2016
2016-11-08,AcelRx Pharmaceuticals To Participate At Three Upcoming Investor Events In November
2016-10-25,AcelRx Pharmaceuticals To Hold Third Quarter Financial Results Conference Call And Webcast On Tuesday, November 1st, 2016
2016-10-13,ACRX: Insiders vs. Shorts
2016-09-27,AcelRx Initiates Phase 3 Study Of Zalviso® In Patients With Moderate-to-Severe Acute Post-Operative Pain
2016-09-22,AcelRx Pharmaceuticals To Present At The Ladenburg Thalmann 2016 Healthcare Conference
2016-09-15,Here's Why AcelRx Pharmaceuticals (ACRX) Stock Gained Today
2016-09-15,AcelRx Reports Positive Results For ARX-04 (sufentanil Sublingual Tablet, 30 Mcg), Including In Elderly Patients And Patients With Organ Impairment, In Third Phase 3 Registration Trial, SAP303
2016-09-14,AcelRx Pharmaceuticals To Announce Topline Results In Phase 3 Study Of ARX-04 In Patients With Post-Operative Moderate-to-Severe Acute Pain
2016-08-31,AcelRx Pharmaceuticals to Participate at Two Upcoming Investor Events in September
2016-08-15,AcelRx Pharmaceuticals' ARX-04 Phase 3 Trial Met Its Primary Endpoint, Reduced Pain Intensity In ER Patients With Moderate-to-Severe Acute Pain
2016-07-26,AcelRx Pharmaceuticals To Hold Second Quarter Financial Results Conference Call And Webcast On Thursday, July 28th, 2016
2016-07-06,AcelRx Pharmaceuticals To Present At Cantor Fitzgerald 2nd Annual Healthcare Conference
2016-06-28,AcelRx Pharmaceuticals Completes Patient Enrollment In Remaining Phase 3 Studies Of ARX-04 As A Potential Treatment Of Moderate-to-Severe Acute Pain
2016-06-27,AcelRx Pharmaceuticals Joins Russell 3000 And Russell 2000 Indexes
2016-06-02,AcelRx Pharmaceuticals To Participate In Three Upcoming Healthcare Investor Events In June
2016-05-04,AcelRx Pharmaceuticals To Present At Two Upcoming Investor Events In May
2016-04-28,AcelRx Pharmaceuticals To Hold First Quarter Financial Results Conference Call And Webcast On Monday, May 2nd, 2016
2016-03-29,AcelRx Pharmaceuticals Names Howard B. Rosen As Chief Executive Officer And Provides Update On Clinical Development Activities And Corporate Priorities For 2016
2016-03-25,AcelRx Publishes A Review Of Hospital-Based Opioid Patient-Controlled Analgesia, Risks And Pharmacoeconomics
2016-03-14,AcelRx Pharmaceuticals Advances ARX-04 into Extension Phase of Open-Label Phase 3 Emergency Room Study
2016-03-07,AcelRx Pharmaceuticals Initiates Phase 3 Study Of ARX-04 In Patients With Post-Operative Moderate-to-Severe Acute Pain
2016-03-03,AcelRx Pharmaceuticals To Hold Annual 2015 Financial Results Conference Call And Webcast On Monday, March 7th, 2016.
2016-03-01,AcelRx Pharmaceuticals To Present At Two Upcoming Investor Events In March
2016-02-25,AcelRx Pharmaceuticals' Moderate-to-Severe Acute Pain Candidate ARX-04 Shows Improved Pain Scores In ER Patients In Interim Phase 3 Analysis
2016-02-03,AcelRx Pharmaceuticals To Present At Two Upcoming Investor Events In February
2016-01-27,First Week of ACRX September 16th Options Trading
2016-01-21,AcelRx Pharmaceuticals Announces Presentation Of Phase 3 Sufentanil Sublingual 30 Mcg Tablet (ARX-04) Data At The European Congress Of Ambulatory Surgery
2016-01-10,AcelRx Pharmaceuticals Announces Anticipated 2016 Milestones
2016-01-08,AcelRx Completes Protocol Review With FDA And Plans To Initiate Phase 3 Open-Label Study (IAP312) For Zalviso™ In 1Q 2016
2015-12-23,AcelRx Pharmaceuticals Receives Notice Of Eligibility For Centralized Review Of ARX-04 From European Medicines Agency
2015-12-14,AcelRx Pharmaceuticals Conducts Pre-NDA Meeting with U.S. Food and Drug Administration for ARX-04
2015-12-02,AcelRx Pharmaceuticals (ACRX) Highlighted As Weak On High Volume
2015-11-23,AcelRx Pharmaceuticals To Present At Piper Jaffray 27th Annual Healthcare Conference
2015-11-13,AcelRx Pharmaceuticals (ACRX) Strong On High Relative Volume Today
2015-11-10,AcelRx Pharmaceuticals To Present At Jefferies 2015 Global Healthcare Conference
2015-11-05,AcelRx Pharmaceuticals To Present At Credit Suisse 24th Annual Healthcare Conference
2015-11-04,AcelRx Pharmaceuticals Presents Data From Phase 3 Clinical Trials Evaluating The Safety And Efficacy Of Zalviso In Obese Surgical Patients
2015-10-26,AcelRx Pharmaceuticals To Hold Business Update And Third Quarter Financial Results Conference Call And Webcast On Thursday, Oct 29th, 2015
2015-10-23,AcelRx Pharmaceuticals Announces Presentation Of Phase 3 Data From ARX-04 Sufentanil Sublingual 30 Mcg Program At The American Society Of Anesthesiology Meeting
2015-10-08,AcelRx Pharmaceuticals Provides Regulatory Update On Zalviso
2015-10-06,AcelRx Pharmaceuticals Announces Initiation Of Clinical Study With ARX-04 In Emergency Room Patients With Moderate-to-Severe Acute Pain
2015-10-02,Amicus, Other Biotech CEOs Should Listen More, Talk Less About FDA Matters
2015-10-01,AcelRx Pharmaceuticals Appoints Gina Ford As Vice President Commercial Strategy
2015-09-24,AcelRx Pharmaceuticals To Host Analyst & Investor Event On October 2, 2015
2015-09-22,AcelRx Pharmaceuticals Reports That The European Commission Has Granted Marketing Authorization For Zalviso™ For Treatment Of Acute Moderate-to-Severe Post-Operative Pain In Adult Patients
2015-09-21,PDL BioPharma Acquires A Portion Of AcelRx Pharmaceuticals' Expected Royalties And Commercial Milestones From Zalviso™ For $65 Million
2015-09-21,AcelRx Pharmaceuticals Receives $65 Million From The Partial Sale Of Zalviso™ European Royalties And Commercial Milestones To PDL BioPharma
2015-09-09,AcelRx Pharmaceuticals' ARX-04 Meets All Endpoints In Pivotal Phase 3 Study For Moderate-to-Severe Acute Pain
2015-08-26,AcelRx Pharmaceuticals To Participate At Three Investor Conferences In September
2015-07-29,AcelRx Pharmaceuticals To Hold Business Update And Second Quarter Financial Results Conference Call And Webcast On Monday, Aug. 3rd, 2015.
2015-07-24,5 Stocks Poised for Breakouts
2015-07-24,AcelRx Announces Positive CHMP Opinion For Zalviso In The Management Of Acute Moderate-to-Severe Post-Operative Pain In Adult Patients
2015-07-14,3 Stocks Under $10 to Trade for Breakouts
2015-07-02,Zalviso™ Phase 3 Orthopedic Results Published In Anesthesiology Demonstrate Significant Reductions In Post-Operative Pain
2015-07-01,10 Worst Biotech Stocks in the NASDAQ
2015-05-22,AcelRx Pharmaceuticals To Present At Two Upcoming Investor Conferences In June
2015-05-14,AcelRx Awarded Contract From Department Of Defense To Advance ARX-04
2015-05-08,Insider Trading Alert - LAD, RSE And ACRX Traded By Insiders
2015-05-01,AcelRx Pharmaceuticals To Participate At Upcoming Investor Conferences In May
2015-04-30,AcelRx Pharmaceuticals To Hold First Quarter Financial Results Conference Call And Webcast On Monday, May 4th, 2015
2015-04-24,Insider Trading Alert - STFC, ACRX And CSC Traded By Insiders
2015-03-23,AcelRx Pharmaceuticals: What Went Wrong and What's on the Horizon for the Struggling Biotech?
2015-03-20,AcelRx Appoints Howard B. Rosen As Interim CEO
2015-03-16,AcelRx Pharmaceuticals Announces Initiation Of Pivotal Phase 3 Trial For ARX-04
2015-03-13,INVESTOR ALERT: Faruqi & Faruqi, LLP Encourages Investors Who Suffered Losses In Excess Of $100,000 Investing In AcelRx Pharmaceuticals, Inc. (ACRX) To Contact The Firm
2015-03-10,AcelRx Pharmaceuticals (ACRX) Stock Extends Losses Today as Jefferies Downgrades
2015-03-09,EQUITY ALERT: The Rosen Law Firm Announces Investigation Of Securities Claims Against AcelRx Pharmaceuticals, Inc. - ACRX
2015-03-09,AcelRx Pharmaceuticals (ACRX) Stock Tanks Today on FDA Demand For Further Zalviso Trials
2015-03-09,AcelRx Pharmaceuticals Is Now Oversold (ACRX)
2015-03-09,SHAREHOLDER ALERT: Pomerantz Law Firm Investigates Claims On Behalf Of Investors Of AcelRx Pharmaceuticals, Inc. - ACRX
2015-03-09,AcelRx Provides Regulatory Update On Zalviso
2015-03-04,AcelRx Pharmaceuticals To Hold Annual 2014 Financial Results Conference Call And Webcast On Monday, March 9th, 2015
2015-02-20,AcelRx Pharmaceuticals To Participate At Two Upcoming Investor Events
2015-02-04,AcelRx Pharmaceuticals To Present At BIO CEO & Investor Conference
2015-01-15,Will the Second Time be a Charm for Biotech AcelRx After Their FDA Rejection?
2015-01-09,5 Stocks Under $10 Setting Up to Trade Higher: Callon Petroleum and More
2014-12-30,AcelRx Pharmaceuticals (ACRX) Downgraded From Hold to Sell
2014-12-29,Ratings Changes Today
2014-12-02,AcelRx Pharmaceuticals Receives CE Mark Approval For Zalviso
2014-11-20,AcelRx Pharmaceuticals To Participate In Four Upcoming Investor Events
2014-11-19,SHAREHOLDER ALERT: Brower Piven Encourages Investors Who Have Losses In Excess Of $100,000 From Investment In AcelRx Pharmaceuticals, Inc. To Contact Brower Piven Before The December 1, 2014 Lead Plaintiff Deadline In Class Action Lawsuit
2014-11-17,UPCOMING DEADLINE: Levi & Korsinsky, LLP Reminds Investors Of Class Action Against AcelRx Pharmaceuticals, Inc. And Its Board Of Directors And A Lead Plaintiff Deadline Of December 1, 2014
2014-11-12,AcelRx Pharmaceuticals (ACRX) Upgraded From Sell to Hold
2014-11-11,AcelRx Pharmaceuticals (ACRX) Stock Rises After Third-Quarter Earnings Report
2014-11-11,Ratings Changes Today
2014-11-10,AcelRx Pharmaceuticals Receives International Standards Organization (ISO) 13485:2003 Certification Of Its Quality Management System
2014-11-07,AcelRx Pharmaceuticals To Participate In Two Upcoming Investor Events
2014-11-06,INVESTOR ALERT: Glancy Binkow & Goldberg LLP Reminds Investors Of The Lead Plaintiff Deadline In The Class Action Lawsuit Against AcelRx Pharmaceuticals, Inc.
2014-11-06,AcelRx Pharmaceuticals To Hold Third Quarter Financial Results Conference Call And Webcast On Monday, November 10, 2014
2014-11-05,Acelrx Pharmaceuticals Announces Management Change
2014-10-27,AcelRx Pharmaceuticals Announces Sublingual Sufentanil Data Presentations At The American College Of Surgeons Meeting
2014-10-22,AcelRx Announces Publication Of Zalviso Phase 3 Abdominal Trial Results
2014-10-16,AcelRx Pharmaceuticals Provides Update On Its Patent Portfolio For Zalviso™ And Its Proprietary Platform Technologies
2014-10-15,SHAREHOLDER ALERT: Brower Piven Encourages Investors Who Have Losses In Excess Of $100,000 From Investment In AcelRx Pharmaceuticals, Inc. To Contact Brower Piven Before The December 1, 2014 Lead Plaintiff Deadline In Class Action Lawsuit
2014-10-07,Harwood Feffer LLP Announces Investigation Of AcelRx Pharmaceuticals, Inc.
2014-10-07,Lifshitz & Miller Law Firm Announces Investigation Of AcelRx Pharmaceuticals, Inc., Ambit Biosciences, Athlon Energy Inc., LipoScience, Inc., Simplicity Bancorp, Inc., And TIBCO Software Inc.
2014-10-07,AcelRx Pharmaceuticals Shareholder Alert: Former SEC Attorney Willie Briscoe And Powers Taylor Investigate Possible Breaches Of Fiduciary Duty By Officers And Directors
2014-10-03,INVESTOR ALERT: Faruqi & Faruqi, LLP Encourages Investors Who Suffered Losses In Excess Of $50,000 Investing In AcelRx Pharmaceuticals, Inc. (ACRX) To Contact The Firm
2014-10-02,INVESTOR ALERT: Class Action Lawsuit Against AcelRx Pharmaceuticals, Inc. Filed By Glancy Binkow & Goldberg LLP
2014-09-29,Strong On High Volume: AcelRx Pharmaceuticals (ACRX)
2014-09-26,Why AcelRx Pharmaceuticals (ACRX) Stock Hit a One-Year Low Today
2014-09-26,AcelRx Pharmaceuticals Provides Regulatory Update On Zalviso™
2014-09-10,AcelRx Announces Publication Of Manuscript Analyzing Cost Of Intravenous Patient-Controlled Analgesia With Opioids
2014-09-04,AcelRx Announces Publication Of Sufentanil Sublingual Tablet System Vs. Intravenous Patient-Controlled Analgesia With Morphine For Postoperative Pain Study Results
2014-08-27,AcelRx Pharmaceuticals To Participate In Two Upcoming Investor Events
2014-08-26,The Best Hedge Fund You've Never Heard Of and Its Top 5 Stock Picks
2014-08-08,AcelRx Pharmaceuticals To Participate In Three Upcoming Investor Events
2014-08-07,AcelRx Pharmaceuticals To Hold Second Quarter Financial Results Conference Call And Webcast On Monday, August 11th, 2014.
2014-08-01,Perilous Reversal Stock: AcelRx Pharmaceuticals (ACRX)
2014-08-01,4 Biotech Stocks Under $10 to Trade for Breakouts
2014-07-29,Today's Dead Cat Bounce Stock: AcelRx Pharmaceuticals (ACRX)
2014-07-28,Why AcelRx Pharmaceuticals (ACRX) Stock Is Plummeting Today
2014-07-28,FDA Rejects AcelRx Painkiller Dispensing Device (Update)
2014-07-28,AcelRx Pharmaceuticals (ACRX) Moving On Heavy Volume In The Pre-Market Hours
2014-07-25,AcelRx Pharmaceuticals Receives Complete Response Letter From FDA For New Drug Application For Zalviso™
2014-07-24,AcelRx Pharmaceuticals Confirms July 27, 2014 PDUFA Date For Zalviso
2014-07-24,4 Biotech Stocks Breaking Out on Big Volume
2014-07-18,Biotech Stock Mailbag: AcelRx, Yellen Aftermath, Nymox
2014-07-14,Biotech Stock Mailbag: MannKind, Bluebird, Northwest Bio, More '14 Tradable Biotech Events
2014-07-07,AcelRx And Grunenthal Announce Submission Of European Marketing Authorization Application For ZALVISO™
2014-07-03,5 Stocks Spiking on Unusual Volume
2014-06-25,First Week of August 16th Options Trading For AcelRx Pharmaceuticals (ACRX)
2014-06-19,AcelRx Pharmaceuticals To Present At The JMP Securities Healthcare Conference
2014-06-06,Oversold Conditions For AcelRx Pharmaceuticals (ACRX)
2014-06-03,Results Of Cost Analysis Study Presented At ISPOR Meeting Identify Intravenous Patient-Controlled Analgesia (IV PCA) Costs Of $200 To $240 For Two Days Of Post-Surgical Pain Management
2014-05-29,AcelRx Pharmaceuticals To Present At The Jefferies Global Healthcare Conference
2014-05-19,AcelRx Pharmaceuticals To Present At The UBS Global Healthcare Conference
2014-05-14,AcelRx Pharmaceuticals is Now Oversold (ACRX)
2014-05-02,AcelRx Pharmaceuticals To Hold First Quarter Financial Results Conference Call And Webcast On Thursday, May 8, 2014
2014-05-01,AcelRx Pharmaceuticals Announces Zalviso&#8482; And ARX-04 Data Presentations At The American Pain Society 33rd Annual Scientific Meeting
2014-04-25,First Week of ACRX December 20th Options Trading
2014-04-04,AcelRx Pharmaceuticals To Present At The 13th Annual Needham Healthcare Conference
2014-03-27,Interesting ACRX Put And Call Options For May 17th
2014-03-25,AcelRx Pharmaceuticals Appoints Timothy E. Morris As Chief Financial Officer
2014-03-07,AcelRx Pharmaceuticals To Participate At The 26th Annual Roth Conference
2014-02-24,AcelRx Pharmaceuticals To Hold Fourth Quarter And Annual 2013 Financial Results Conference Call And Webcast On Monday, March 3, 2014
2014-02-05,AcelRx Pharmaceuticals To Participate In Three Upcoming Investor Events
2013-12-30,First Week of ACRX February 2014 Options Trading
2013-12-19,AcelRx Secures $40 Million Credit Facility With Hercules Technology Growth Capital
2013-12-16,AcelRx And Grunenthal Announce Collaboration For EU Commercialization Of ZALVISO&#8482;
2013-12-13,AcelRx Pharmaceuticals Presents ARX-04 Dose-Finding Phase 2 Study Data At Anesthesia Medical Conference
2013-12-11,AcelRx Pharmaceuticals Adds New Board Member
2013-12-02,Zalviso&#8482; New Drug Application Accepted For Filing By FDA
2013-11-26,AcelRx Pharmaceuticals To Present At The 25th Annual Piper Jaffray Healthcare Conference
2013-11-19,First Week Of ACRX January 2014 Options Trading
2013-11-13,5 Stocks With Big Insider Buying
2013-11-13,Top Insider Trades: AGCO VVUS INWK ACRX
2013-11-06,Oversold Conditions For AcelRx Pharmaceuticals (ACRX)
2013-11-05,Top Insider Trades: ACW ZINC ACRX FCX
2013-10-23,First Week Of ACRX June 2014 Options Trading
2013-10-22,AcelRx Pharmaceuticals To Hold Third Quarter 2013 Financial Results Conference Call And Webcast On November 5, 2013
2013-10-15,AcelRx Pharmaceuticals Announces Data Presentations For Zalviso™ At US And International Medical Meetings
2013-10-14,AcelRx Pharmaceuticals Becomes Oversold (ACRX)
2013-10-08,AcelRx Pharmaceuticals Provides Update On Its Patent Portfolio For Zalviso™ And Its Proprietary Platform Technologies
2013-09-30,AcelRx Pharmaceuticals Submits New Drug Application To The FDA For Zalviso™
2013-09-27,5 Stocks Poised for Breakouts
2013-09-04,David H. Chung Joins AcelRx Pharmaceuticals As Chief Commercial Officer
2013-08-30,AcelRx Pharmaceuticals To Present At The Stifel Healthcare Conference 2013
2013-08-05,5 Stocks Ready to Break Out
2013-08-05,AcelRx Pharmaceuticals To Present At Canaccord Genuity 33rd Annual Growth Conference
2013-08-02,AcelRx Pharmaceuticals To Hold Second Quarter 2013 Financial Results Conference Call And Webcast On August 12, 2013
2013-07-31,5 Stocks With Big Insider Buying
2013-07-25,Top Insider Trades: ACRX EBAY RLGY BERY
2013-07-23,AcelRx Pharmaceuticals Announces Closing Of Public Offering And Exercise Of Option To Purchase Additional Shares
2013-07-18,AcelRx Pharmaceuticals Announces Pricing Of Public Offering Of Common Stock
2013-07-17,AcelRx Pharmaceuticals Announces Proposed Public Offering Of Common Stock
2013-07-08,5 Stocks Spiking on Unusual Volume
2013-07-02,AcelRx Pharmaceuticals Joins Russell Global And Russell 3000 Indexes
